Preclinical Evaluation of Ga-DOTA-Minigastrin for the Detection of Cholecystokinin-2/Gastrin Receptor-Positive Tumors

Preclinical Evaluation of Ga-DOTA-Minigastrin for the Detection of Cholecystokinin-2/Gastrin Receptor-Positive Tumors

In comparison to somatostatin receptor scintigraphy, gastrin receptor scintigraphy using 111 In-DTPA-minigastrin (MG0) showed added value in diagnosing neuroendocrine tumors. We investigated whether the 68 Ga-labeled gastrin analogue DOTA-MG0 is suited for positron emission tomography (PET), which c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maarten Brom, Lieke Joosten, Peter Laverman, Wim J.G. Oyen, Martin Béhé, Martin Gotthardt, Otto C. Boerman
Format:	Article
Language:	English
Published:	SAGE Publishing 2011-03-01
Series:	Molecular Imaging
Online Access:	https://doi.org/10.2310/7290.2010.00032
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In Vitro and In Vivo Characterization of Three Ga- and In-Labeled Peptides for Cholecystokinin Receptor Imaging
by: Susan Roosenburg, et al.
Published: (2012-09-01)

Current Work on Gastrin
by: CN Williams
Published: (1994-01-01)

F-2-Deoxy-2-Fluoro-D-Glucose Positron Emission Tomography, Computed Tomography, and Magnetic Resonance Imaging for the Detection of Experimental Colorectal Liver Metastases
by: Gabie M. de Jong, et al.
Published: (2012-03-01)

Cholecystokinin facilitates the formation of long-term heterosynaptic plasticity in the distal subiculum
by: Fengwen Huang, et al.
Published: (2025-02-01)

Enpostil Lowers Elevated Serum Gastrin Concentrations in Patients with Pernicious Anemia
by: P Kirdeikis, et al.
Published: (1991-01-01)

Case report: Detecting giant cell arteritis in [68Ga]Ga-DOTA-Siglec-9-PET/CT
by: Simon M. Petzinna, et al.
Published: (2024-12-01)

Cholecystokinin (CCK) Is a Mediator Between Nutritional Intake and Gonadal Development in Teleosts
by: Hangyu Li, et al.
Published: (2025-01-01)

Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/MRI in the Preoperative Diagnosis of Gastric Cancer
by: Tao Du, et al.
Published: (2023-01-01)

Cholecystokinin Inhibits Inducible Nitric Oxide Synthase Expression by Lipopolysaccharide-Stimulated Peritoneal Macrophages
by: Rafael Simone Saia, et al.
Published: (2014-01-01)

Synthesis of Poly[APMA]-DOTA-Cu Conjugates for Interventional Radionuclide Therapy of Prostate Cancer: Assessment of Intratumoral Retention by Micro–Positron Emission Tomography
by: Jianchao Yuan, et al.
Published: (2007-01-01)

Study on the value of gastrin 17 and aldehyde dehydrogenase 1 in gastric juice for early diagnosis in gastric cancer
by: Yanfang Wang, et al.
Published: (2025-01-01)

Treatment with Octreotide in Patients with Well-Differentiated Neuroendocrine Tumors of the Ileum: Prognostic Stratification with Ga-68-DOTA-TATE Positron Emission Tomography
by: Walter Koch, et al.
Published: (2014-06-01)

Immunocytochemical and Morphometric Studies of Gastrin-, Somatostatin- and Serotonin-Producing Cells in the Stomach and Duodenum of Patients with Acid Peptic Disorders
by: WR Yacoub, et al.
Published: (1996-01-01)

Genetic variability in the cholecystokinin A receptor affects lipid profile and glucose tolerance in patients with polycystic ovary syndrome
by: Eva Drnovsek, et al.
Published: (2022-06-01)

Pretreatment With Fragments of Substance-P or With Cholecystokinin Differentially Affects Recovery From Sub-Total Nigrostriatal 6-Hydroxydopamine Lesion
by: S. Nikolaus, et al.
Published: (1999-01-01)

Synthesis and Characterization of a Gd-DOTA--Permeation Peptide for Magnetic Resonance Relaxation Enhancement of Intracellular Targets
by: Andrew M. Prantner, et al.
Published: (2003-10-01)

Position for Site-Specific Attachment of a DOTA Chelator to Synthetic Affibody Molecules Has a Different Influence on the Targeting Properties of Ga-Compared to In-Labeled Conjugates
by: Hadis Honarvar, et al.
Published: (2014-12-01)

Lack of Effect of H2-Receptor Antagonists and Antacids on the Gastric and Duodenal Gastrin-, Somatostatin- and Serotonin-Producing Cells in Patients with Acid Peptic Disorders
by: WR Yacoub, et al.
Published: (1996-01-01)

Treatment options for Achilles tendinopathy: a scoping review of preclinical studies
by: Nathanael Opoku Agyeman-Prempeh, et al.
Published: (2025-01-01)

FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy
by: Liang Zhao, et al.
Published: (2025-01-01)

Leukotrienes as Modifiers of Preclinical Atherosclerosis?
by: Graziano Riccioni, et al.
Published: (2012-01-01)

Evaluation of [Cu]Cu-DOTA and [Cu]Cu-CB-TE2A Chelates for Targeted Positron Emission Tomography with an αβ-Specific Peptide
by: Sven H. Hausner, et al.
Published: (2009-03-01)

The Use of a Meckel's Diverticulum in the Creation of an Orthotopic Neobladder in Case of a Short MesoIleum: A Case Report
by: Wim Van Haute, et al.
Published: (2009-01-01)

Radiochemistry and Preclinical PET Imaging of Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen
by: Eleni Gourni PhD, et al.
Published: (2017-10-01)

Preclinical Evidences for an Antimanic Effect of Carvedilol
by: Greicy Coelho de Souza, et al.
Published: (2015-01-01)

In Vitro and In Vivo Evaluation of Alexa Fluor 680-Bombesin[7–14]NH Peptide Conjugate, a High-Affinity Fluorescent Probe with High Selectivity for the Gastrin-Releasing Peptide Receptor
by: Lixin Ma, et al.
Published: (2007-05-01)

Internal Dosimetry in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-[DOTA0-Tyr3] Octerotate: A Single-Center Experience
by: Elahe Mahmoudi, et al.
Published: (2025-01-01)

Synthesis and Characterization of Theranostic Poly(HPMA)-c(RGDyK)-DOTA-Cu Copolymer Targeting Tumor Angiogenesis: Tumor Localization Visualized by Positron Emission Tomography
by: Jianchao Yuan, et al.
Published: (2013-05-01)

Quantitative accuracy of preclinical in ovo PET/MRI: influence of attenuation and quantification methods
by: Theresa Balber, et al.
Published: (2025-01-01)

Editorial: Preclinical animal models and measures of pain: improving predictive validity for analgesic drug development - volume II
by: Anke Tappe-Theodor, et al.
Published: (2025-01-01)

Preclinical Science Regarding Cannabinoids as Analgesics: An Overview
by: ME Lynch
Published: (2005-01-01)

Rättspsykiatrins storkonsumenter
by: Albert J. Boerman
Published: (1992-08-01)

Auch eine Gewerkschaft? Der Deutschnationale Handlungsgehilfenverband und die Angestellten
by: Martin Otto
Published: (2022-10-01)

Phenotypic Presentation of Children with Joint Hypermobility: Preclinical Signs
by: Mateus Marino Lamari, et al.
Published: (2025-01-01)

Insights from in vivo preclinical cancer studies with histotripsy
by: Tejaswi Worlikar, et al.
Published: (2024-12-01)

Guidance for Methods Descriptions Used in Preclinical Imaging Papers
by: David Stout, et al.
Published: (2013-10-01)

Preclinical evaluation and preliminary clinical study of 68Ga-NODAGA-NM-01 for PET imaging of PD-L1 expression
by: Lingzhou Zhao, et al.
Published: (2025-01-01)

Advances in preclinical and clinical studies of oncolytic virus combination therapy
by: Wenlong Du, et al.
Published: (2025-02-01)

Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer
by: Lixuan Tang, et al.
Published: (2025-01-01)

Creation of a Multimodal Telemedicine Curriculum for Preclinical Medical Students
by: Marguerite Costich, et al.
Published: (2025-01-01)